Vycor Medical INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Vycor Medical reported increased revenue and reduced net losses in 2025, driven by international growth, but faces substantial doubt about its ability to continue as a going concern.
OQB
Vycor Medical's 2024 10-K filing reveals a revenue increase driven by US sales, but also highlights concerns about the company's ability to continue as a going concern due to accumulated losses and working capital deficiency.
OQB
10-K: Vycor Medical Inc. Reports 22% Revenue Increase in 2023, Achieves Positive Cash Operating Income
Vycor Medical, Inc. saw a 22% increase in revenue for its medical device sales in 2023 and achieved positive cash operating income for the year.